Compare ICG & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICG | FORA |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Computer Software: Prepackaged Software |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.2M | 67.3M |
| IPO Year | 2022 | 2020 |
| Metric | ICG | FORA |
|---|---|---|
| Price | $0.95 | $2.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.25 | N/A |
| AVG Volume (30 Days) | ★ 63.9K | 44.3K |
| Earning Date | 05-21-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,256,919.00 |
| Revenue This Year | N/A | $8.44 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.80 | ★ N/A |
| Revenue Growth | N/A | ★ 50.13 |
| 52 Week Low | $0.89 | $1.64 |
| 52 Week High | $3.22 | $2.71 |
| Indicator | ICG | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 27.31 | 64.06 |
| Support Level | N/A | $2.05 |
| Resistance Level | $1.36 | $2.20 |
| Average True Range (ATR) | 0.09 | 0.01 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 7.07 | 66.67 |
Intchains Group Ltd is an inventive altcoins development company that engages in the provision of altcoin mining products, the strategic acquisition and holding of Ethereum-based cryptocurrencies and the active development of inventive Web3 applications. The company offers high-performance mining products including altcoin mining machines incorporating its ASIC chips that have high computing power and superior power efficiency, ASIC chips and ancillary software and hardware, all of which cater to the evolving needs of the blockchain industry. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.